Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Genome Biologics identifies novel tissue-specific RNAi therapies targeting the transcriptome of cardiovascular and cardiometabolic disease
Connecting human and artificial intelligence to revolutionize emergency care
Creapaper develops an innovative raw material for paper production that is made mostly out of grass fiber.
Vatorex enhances honey bee health through an effective and practicable hyperthermic system to fight the varroa mite.
INVOLI provides real-time air traffic data to drones and airports for operation optimization and compliance
Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.
ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.
Allero Therapeutics is a biopharmaceutical company.
Gpa Innova design and develops machinery for metal finishing.
Treat your customers as individuals - provide personalized products using our innovative 3D printing solutions. Food. Personal Care. Pharma.
SwissDeCode helps food manufacturers to grow and produce food that is safe to eat by offering a rapid onsite DNA test.
Sally R is a Swedish startup bringing down space technology to earth to secure indoor air quality in real estate and energy performance.
vadeCity develops intelligent solutions that respond to the needs of citizens, organizations and municipalities in matters of mobility.
MoonBikes manufactures innovative, zero-emission ultra-light electric snow vehicles.
Cortexia provides to the cities worldwide an objective and automatic measurement system, based on intelligent vision.
Utonomy provides smart gas grid technology to increase network efficiency, reduce methane emissions and increase biomethane injection.
Invention, design and manufacturing of intralogistics automation and machinery solutions.
Aenitis Technologies is a French start-up resulting from the work of Mauricio HOYOS
Award-winning, sustainable tyre manufacturer, and the first company in the world capable of mass-producing reusable, pneumatic tyres.
ChemiCare is committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases.
Sofi Filtration is a Finnish provider of innovative industrial water filtration technology.
Healthplus.ai enables proactive surgery care
Blubrake aims to make future mobility greener, smarter and safer thanks to its cutting-edge technologies for light electric vehicles
Else Nutrition offers plant-based nutrition products for the infant, toddler, children, and adult markets.
EISMEA has invested in 614 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
EISMEA's top investment sectors include Biotechnology, Pharmaceutical, Health Care, Industrial Engineering, Mechanical Engineering. The firm invests across 54 different industry categories.
Among tracked funding rounds, Creapaper received $23.2M in a Series B round. EISMEA's total known invested capital is $2.3B.
EISMEA's average investment size is $5.3M across its portfolio of 614 companies.
Recent EISMEA portfolio additions include Genome Biologics, NICO.LAB, Creapaper, Vatorex, INVOLI. These companies were founded in 2020 or later.